TB-500

Research Overview

Thymosin Beta-4, the parent compound of TB-500, was first identified in the thymus gland and has been studied since the 1960s. The synthetic fragment TB-500 focuses on the active region responsible for actin binding and cell motility. Research published in the Annals of the New York Academy of Sciences and other peer-reviewed journals has examined its role in upregulating actin in cell culture models, promoting cell migration in wound healing assays, and modulating inflammatory markers in animal models. The peptide has been studied in equine research, dermal wound models in rodents, and cardiac tissue models. Its interaction with actin polymerization makes it a compound of interest for researchers studying cytoskeletal dynamics and cellular repair mechanisms.

Key Research Findings

• 1

  Promoted dermal wound repair in rodent models through enhanced cell migration (Malinda et al., 1999)

• 2

  Upregulated actin expression in cell culture studies, facilitating cytoskeletal organization

• 3

  Demonstrated anti-inflammatory marker modulation in animal models of tissue injury

• 4

  Studied extensively in equine research for soft tissue investigations

• 5

  Observed promotion of blood vessel growth in chicken chorioallantoic membrane models

• 6

  Shown to interact with actin-binding sites critical for cell motility in vitro

Where to Buy TB-500

Our top-ranked vendors for sourcing research-grade TB-500. All vendors below publish third-party COAs and have been independently evaluated.

Related Peptides